Deals
Gyrus Capital's Essential Pharma refinances, inks two deals
In parallel with the refinancing, Essential Pharma completed two M&A deals in December
CVC invests in FutureLife
CVC acquires a co-controlling stake alongside current investor Hartenberg Holding
Maven exits Healthpoint in trade sale
GP reaps a 3.1x return on its investment in the consumer healthcare and beauty supplier
Clessidra acquires Impresoft
Impresoft was expected to have an enterprise value between 9x-11x its 2021 EBITDA
Mandarin's Italcer to collect NBOs in early January
Company will be marketed off EUR 65m EBITDA expected for 2021 and more than EUR 70m for 2022
Perusa eyes Müpro exit
Formal sale process is expected next year with IMs to be distributed in the first half of 2022
Cegid sponsor could pursue IPO among mid-term exit options
Mandates could be awarded in the first half of next year, one source says
Livingbridge sells Southern Communications
GP appointed Oakley Advisory to launch the sale over the summer
Lonsdale exits P2 to Waterland-backed Valcon
Deal is the fifth exit of the year for the lower-mid-market private equity firm
Capiton buys Betonbau Group
GP is deploying equity via Capiton VI, which held a final close in November 2021 on EUR 504m
CD&R forms USD 4bn special-purpose vehicle for Belron stake
CD&R is also selling part of its stake to existing backers, including Hellman & Friedman
HungryPanda raises USD 130m in Series D round
London-headquartered company has now raised USD 220m over the last three years
BC's Springer Nature to begin sale of road safety assets in 2022
Investment in Springer Nature Group was extended into a continuation fund in June
ArchiMed preps Bomi auction
ArchiMed launched a EUR 70m takeover bid for Bomi in March 2019
Carlyle buys Altadia from Lone Star
Lone Star Funds bought Esmalglass for EUR 605m in 2017, forming Altadia in 2021 via a merger with FTC
ArchiMed buys lab analysis company Carso
Selling shareholders include private equity firms EMZ Partners, Etoile ID, Unigrains, Raise and Siparex
Atomico et al. in USD 200m Series D for Infarm
Vcs raised USD 200m in Series D for Infarm at a valuation of over USD 1bn
Auction for Bridgepoint's Element to kick off next year
Sale of Element Materials Technology is likely to be highly contested by other private equity firms
GL Education attracts large-cap PE firms ahead of Q1 sale
Baird is advising incumbent sponsor Levine Leichtman Capital Partners on the exit
MBO & Co closes fifth fund on EUR 320m
GP's latest SME-focused fund took six months to raise and closed above its target
Fortress buys Punch Pubs from Patron Capital
Patron Capital Partners and May Capital acquired the pub operator in a GBP 1.8bn deal in 2017
PE-backed Ardonagh secures further investment at USD 7.5bn valuation
US private equity houses HPS and MDP merged five insurance firms to form Ardonagh in 2017
PAI sells Asmodee to Embracer in EUR 3bn deal
EBITDA for the France-based games business has risen from EUR 90m to EUR 240m under PAI's ownership
Aurelius in conversations with sponsors for NDS Group exit
Aurelius acquired NDS Group, then called Hellanor, from Nordic Forum Holding in 2018